UA73718C2 - Therapeutic vector expressing foreign dna, coding cat's cd80, cat's cd86, cat's cd28 or cat's ctla-4 and use thereof - Google Patents

Therapeutic vector expressing foreign dna, coding cat's cd80, cat's cd86, cat's cd28 or cat's ctla-4 and use thereof Download PDF

Info

Publication number: UA73718C2
Authority: UA; Ukraine
Prior art keywords: feline; virus; gene; recombinant; cat
Prior art date: 1998-05-01

Application number

UA2000116863A

Other languages

English (en)

Ukrainian (uk)

Original Assignee

Schering Plough Ltd

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

1998-05-01

Filing date

1999-04-30

Publication date

2005-09-15

1999-04-30 Application filed by Schering Plough Ltd filed Critical Schering Plough Ltd

2005-09-15 Publication of UA73718C2 publication Critical patent/UA73718C2/uk

Links

241000282326 Felis catus Species 0.000 title claims abstract description 289
239000013598 vector Substances 0.000 title claims abstract description 219
230000001225 therapeutic effect Effects 0.000 title claims abstract 43
108090000623 proteins and genes Proteins 0.000 claims abstract description 741
238000000034 method Methods 0.000 claims abstract description 213
102000004169 proteins and genes Human genes 0.000 claims abstract description 70
230000028993 immune response Effects 0.000 claims abstract description 66
150000007523 nucleic acids Chemical class 0.000 claims abstract description 63
230000002163 immunogen Effects 0.000 claims abstract description 60
108020004707 nucleic acids Proteins 0.000 claims abstract description 60
102000039446 nucleic acids Human genes 0.000 claims abstract description 60
201000010099 disease Diseases 0.000 claims abstract description 41
208000037265 diseases, disorders, signs and symptoms Diseases 0.000 claims abstract description 41
229940021747 therapeutic vaccine Drugs 0.000 claims abstract 5
238000002560 therapeutic procedure Methods 0.000 claims abstract 2
241000282324 Felis Species 0.000 claims description 511
241000700605 Viruses Species 0.000 claims description 257
239000012634 fragment Substances 0.000 claims description 220
230000014509 gene expression Effects 0.000 claims description 153
241000701087 Felid alphaherpesvirus 1 Species 0.000 claims description 91
241000700565 Swinepox virus Species 0.000 claims description 69
241000700638 Raccoonpox virus Species 0.000 claims description 68
239000004365 Protease Substances 0.000 claims description 52
239000003550 marker Substances 0.000 claims description 49
239000000427 antigen Substances 0.000 claims description 45
108091007433 antigens Proteins 0.000 claims description 43
102000036639 antigens Human genes 0.000 claims description 43
239000000203 mixture Substances 0.000 claims description 33
244000052769 pathogen Species 0.000 claims description 31
241000713800 Feline immunodeficiency virus Species 0.000 claims description 25
230000003612 virological effect Effects 0.000 claims description 25
206010028980 Neoplasm Diseases 0.000 claims description 21
230000001717 pathogenic effect Effects 0.000 claims description 21
241000714165 Feline leukemia virus Species 0.000 claims description 19
238000013519 translation Methods 0.000 claims description 15
108020004999 messenger RNA Proteins 0.000 claims description 14
230000003053 immunization Effects 0.000 claims description 13
238000011282 treatment Methods 0.000 claims description 11
241000711475 Feline infectious peritonitis virus Species 0.000 claims description 8
208000005098 feline infectious peritonitis Diseases 0.000 claims description 8
238000005728 strengthening Methods 0.000 claims description 8
208000035473 Communicable disease Diseases 0.000 claims description 7
101710091045 Envelope protein Proteins 0.000 claims description 7
101710188315 Protein X Proteins 0.000 claims description 7
241000725579 Feline coronavirus Species 0.000 claims description 6
230000000692 anti-sense effect Effects 0.000 claims description 6
241000714201 Feline calicivirus Species 0.000 claims description 5
244000052616 bacterial pathogen Species 0.000 claims description 5
241000519954 Feline foamy virus Species 0.000 claims description 4
241000701915 Feline panleukopenia virus Species 0.000 claims description 4
241000702679 Feline rotavirus Species 0.000 claims description 4
241000714174 Feline sarcoma virus Species 0.000 claims description 4
244000045947 parasite Species 0.000 claims description 4
241000606161 Chlamydia Species 0.000 claims description 3
241001480512 Mammalian orthoreovirus 3 Species 0.000 claims description 3
241000711798 Rabies lyssavirus Species 0.000 claims description 3
108010005774 beta-Galactosidase Proteins 0.000 claims description 3
230000008105 immune reaction Effects 0.000 claims description 3
210000000056 organ Anatomy 0.000 claims description 3
102100026189 Beta-galactosidase Human genes 0.000 claims 1
102100027723 Endogenous retrovirus group K member 6 Rec protein Human genes 0.000 claims 1
101000807236 Human cytomegalovirus (strain AD169) Membrane glycoprotein US3 Proteins 0.000 claims 1
230000009885 systemic effect Effects 0.000 claims 1
102000008203 CTLA-4 Antigen Human genes 0.000 abstract 1
108010021064 CTLA-4 Antigen Proteins 0.000 abstract 1
101000914514 Homo sapiens T-cell-specific surface glycoprotein CD28 Proteins 0.000 abstract 1
101000914484 Homo sapiens T-lymphocyte activation antigen CD80 Proteins 0.000 abstract 1
102100027213 T-cell-specific surface glycoprotein CD28 Human genes 0.000 abstract 1
102100027222 T-lymphocyte activation antigen CD80 Human genes 0.000 abstract 1
210000004027 cell Anatomy 0.000 description 186
108020004414 DNA Proteins 0.000 description 149
235000010469 Glycine max Nutrition 0.000 description 128
229960005486 vaccine Drugs 0.000 description 124
239000013615 primer Substances 0.000 description 111
244000068988 Glycine max Species 0.000 description 110
238000003752 polymerase chain reaction Methods 0.000 description 78
239000013612 plasmid Substances 0.000 description 73
108091005804 Peptidases Proteins 0.000 description 72
239000002299 complementary DNA Substances 0.000 description 64
238000012216 screening Methods 0.000 description 61
238000003556 assay Methods 0.000 description 58
238000002744 homologous recombination Methods 0.000 description 54
230000006801 homologous recombination Effects 0.000 description 54
102000004196 processed proteins & peptides Human genes 0.000 description 54
108090000765 processed proteins & peptides Proteins 0.000 description 54
235000018102 proteins Nutrition 0.000 description 54
150000001413 amino acids Chemical group 0.000 description 52
229920001184 polypeptide Polymers 0.000 description 50
238000001262 western blot Methods 0.000 description 47
241000701022 Cytomegalovirus Species 0.000 description 43
108700026244 Open Reading Frames Proteins 0.000 description 40
238000013518 transcription Methods 0.000 description 40
230000035897 transcription Effects 0.000 description 40
102100038132 Endogenous retrovirus group K member 6 Pro protein Human genes 0.000 description 37
230000015572 biosynthetic process Effects 0.000 description 36
241000282414 Homo sapiens Species 0.000 description 34
235000019419 proteases Nutrition 0.000 description 34
238000000746 purification Methods 0.000 description 34
238000001890 transfection Methods 0.000 description 34
101100505657 Drosophila melanogaster grim gene Proteins 0.000 description 31
239000002609 medium Substances 0.000 description 31
239000007858 starting material Substances 0.000 description 31
108091032973 (ribonucleotides)n+m Proteins 0.000 description 30
238000004458 analytical method Methods 0.000 description 30
238000000732 glass refractive index measurement Methods 0.000 description 30
208000015181 infectious disease Diseases 0.000 description 29
239000000047 product Substances 0.000 description 29
101150085662 cydA gene Proteins 0.000 description 28
238000003780 insertion Methods 0.000 description 28
230000037431 insertion Effects 0.000 description 28
230000008774 maternal effect Effects 0.000 description 28
238000006243 chemical reaction Methods 0.000 description 27
229940024606 amino acid Drugs 0.000 description 25
235000001014 amino acid Nutrition 0.000 description 25
239000000499 gel Substances 0.000 description 24
102000004190 Enzymes Human genes 0.000 description 23
108090000790 Enzymes Proteins 0.000 description 23
238000004519 manufacturing process Methods 0.000 description 23
230000027455 binding Effects 0.000 description 22
239000013603 viral vector Substances 0.000 description 21
239000002773 nucleotide Substances 0.000 description 19
230000004913 activation Effects 0.000 description 18
230000013595 glycosylation Effects 0.000 description 18
238000006206 glycosylation reaction Methods 0.000 description 18
229940126619 mouse monoclonal antibody Drugs 0.000 description 18
241000283707 Capra Species 0.000 description 16
241000701063 Gallid alphaherpesvirus 1 Species 0.000 description 16
102100034349 Integrase Human genes 0.000 description 16
108020004511 Recombinant DNA Proteins 0.000 description 16
210000001744 T-lymphocyte Anatomy 0.000 description 16
238000012217 deletion Methods 0.000 description 16
230000037430 deletion Effects 0.000 description 16
239000000463 material Substances 0.000 description 16
230000036961 partial effect Effects 0.000 description 16
238000010839 reverse transcription Methods 0.000 description 16
241001529453 unidentified herpesvirus Species 0.000 description 16
239000013592 cell lysate Substances 0.000 description 15
238000010367 cloning Methods 0.000 description 15
239000012528 membrane Substances 0.000 description 15
125000003729 nucleotide group Chemical group 0.000 description 15
239000013600 plasmid vector Substances 0.000 description 15
108091028043 Nucleic acid sequence Proteins 0.000 description 14
241000283973 Oryctolagus cuniculus Species 0.000 description 14
239000000523 sample Substances 0.000 description 14
239000007983 Tris buffer Substances 0.000 description 13
230000004186 co-expression Effects 0.000 description 13
230000001965 increasing effect Effects 0.000 description 13
108010057023 protease Re Proteins 0.000 description 13
239000000243 solution Substances 0.000 description 13
LENZDBCJOHFCAS-UHFFFAOYSA-N tris Chemical compound OCC(N)(CO)CO LENZDBCJOHFCAS-UHFFFAOYSA-N 0.000 description 13
PXHVJJICTQNCMI-UHFFFAOYSA-N Nickel Chemical compound [Ni] PXHVJJICTQNCMI-UHFFFAOYSA-N 0.000 description 12
206010058874 Viraemia Diseases 0.000 description 12
230000002441 reversible effect Effects 0.000 description 12
239000000758 substrate Substances 0.000 description 12
239000003153 chemical reaction reagent Substances 0.000 description 11
238000002255 vaccination Methods 0.000 description 11
108010092799 RNA-directed DNA polymerase Proteins 0.000 description 10
PXIPVTKHYLBLMZ-UHFFFAOYSA-N Sodium azide Chemical compound [Na+].[N-]=[N+]=[N-] PXIPVTKHYLBLMZ-UHFFFAOYSA-N 0.000 description 10
DBMJMQXJHONAFJ-UHFFFAOYSA-M Sodium laurylsulphate Chemical compound [Na+].CCCCCCCCCCCCOS([O-])(=O)=O DBMJMQXJHONAFJ-UHFFFAOYSA-M 0.000 description 10
230000002950 deficient Effects 0.000 description 10
239000003446 ligand Substances 0.000 description 10
108020003175 receptors Proteins 0.000 description 10
102000005962 receptors Human genes 0.000 description 10
XLYOFNOQVPJJNP-UHFFFAOYSA-N water Chemical compound O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 10
OKKJLVBELUTLKV-UHFFFAOYSA-N Methanol Chemical compound OC OKKJLVBELUTLKV-UHFFFAOYSA-N 0.000 description 9
230000004071 biological effect Effects 0.000 description 9
230000033228 biological regulation Effects 0.000 description 9
239000000872 buffer Substances 0.000 description 9
230000036039 immunity Effects 0.000 description 9
230000003993 interaction Effects 0.000 description 9
239000011541 reaction mixture Substances 0.000 description 9
239000006228 supernatant Substances 0.000 description 9
229920000936 Agarose Polymers 0.000 description 8
108091003079 Bovine Serum Albumin Proteins 0.000 description 8
102000004127 Cytokines Human genes 0.000 description 8
108090000695 Cytokines Proteins 0.000 description 8
102000003886 Glycoproteins Human genes 0.000 description 8
108090000288 Glycoproteins Proteins 0.000 description 8
241000699670 Mus sp. Species 0.000 description 8
102000035195 Peptidases Human genes 0.000 description 8
239000011543 agarose gel Substances 0.000 description 8
210000004899 c-terminal region Anatomy 0.000 description 8
101150060378 cidA gene Proteins 0.000 description 8
238000004140 cleaning Methods 0.000 description 8
230000000295 complement effect Effects 0.000 description 8
230000000120 cytopathologic effect Effects 0.000 description 8
238000001514 detection method Methods 0.000 description 8
239000003814 drug Substances 0.000 description 8
239000012091 fetal bovine serum Substances 0.000 description 8
238000002955 isolation Methods 0.000 description 8
244000000010 microbial pathogen Species 0.000 description 8
229920002401 polyacrylamide Polymers 0.000 description 8
230000001105 regulatory effect Effects 0.000 description 8
230000003362 replicative effect Effects 0.000 description 8
230000004044 response Effects 0.000 description 8
238000012163 sequencing technique Methods 0.000 description 8
108091026890 Coding region Proteins 0.000 description 7
241001465754 Metazoa Species 0.000 description 7
239000013553 cell monolayer Substances 0.000 description 7
238000011161 development Methods 0.000 description 7
230000012010 growth Effects 0.000 description 7
HNDVDQJCIGZPNO-UHFFFAOYSA-N histidine Natural products OC(=O)C(N)CC1=CN=CN1 HNDVDQJCIGZPNO-UHFFFAOYSA-N 0.000 description 7
230000003308 immunostimulating effect Effects 0.000 description 7
210000002966 serum Anatomy 0.000 description 7
210000004881 tumor cell Anatomy 0.000 description 7
QKNYBSVHEMOAJP-UHFFFAOYSA-N 2-amino-2-(hydroxymethyl)propane-1,3-diol;hydron;chloride Chemical compound Cl.OCC(N)(CO)CO QKNYBSVHEMOAJP-UHFFFAOYSA-N 0.000 description 6
241001529936 Murinae Species 0.000 description 6
239000012190 activator Substances 0.000 description 6
230000003321 amplification Effects 0.000 description 6
238000005119 centrifugation Methods 0.000 description 6
230000000694 effects Effects 0.000 description 6
239000013604 expression vector Substances 0.000 description 6
238000005304 joining Methods 0.000 description 6
239000010410 layer Substances 0.000 description 6
239000011159 matrix material Substances 0.000 description 6
239000013642 negative control Substances 0.000 description 6
229910052759 nickel Inorganic materials 0.000 description 6
238000003199 nucleic acid amplification method Methods 0.000 description 6
239000008188 pellet Substances 0.000 description 6
238000002360 preparation method Methods 0.000 description 6
210000000952 spleen Anatomy 0.000 description 6
210000004989 spleen cell Anatomy 0.000 description 6
UCSJYZPVAKXKNQ-HZYVHMACSA-N streptomycin Chemical compound CN[C@H]1[C@H](O)[C@@H](O)[C@H](CO)O[C@H]1O[C@@H]1[C@](C=O)(O)[C@H](C)O[C@H]1O[C@@H]1[C@@H](NC(N)=N)[C@H](O)[C@@H](NC(N)=N)[C@H](O)[C@H]1O UCSJYZPVAKXKNQ-HZYVHMACSA-N 0.000 description 6
229940124597 therapeutic agent Drugs 0.000 description 6
210000001519 tissue Anatomy 0.000 description 6
101150101112 7 gene Proteins 0.000 description 5
101150008021 80 gene Proteins 0.000 description 5
LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 5
241000699666 Mus <mouse, genus> Species 0.000 description 5
239000013599 cloning vector Substances 0.000 description 5
238000010276 construction Methods 0.000 description 5
239000000975 dye Substances 0.000 description 5
238000001962 electrophoresis Methods 0.000 description 5
230000002708 enhancing effect Effects 0.000 description 5
235000012907 honey Nutrition 0.000 description 5
210000004408 hybridoma Anatomy 0.000 description 5
239000002054 inoculum Substances 0.000 description 5
210000003819 peripheral blood mononuclear cell Anatomy 0.000 description 5
230000002085 persistent effect Effects 0.000 description 5
230000007505 plaque formation Effects 0.000 description 5
230000022532 regulation of transcription, DNA-dependent Effects 0.000 description 5
108091008146 restriction endonucleases Proteins 0.000 description 5
239000002356 single layer Substances 0.000 description 5
238000006467 substitution reaction Methods 0.000 description 5
230000001629 suppression Effects 0.000 description 5
238000003786 synthesis reaction Methods 0.000 description 5
238000012360 testing method Methods 0.000 description 5
238000011144 upstream manufacturing Methods 0.000 description 5
208000023275 Autoimmune disease Diseases 0.000 description 4
108020001019 DNA Primers Proteins 0.000 description 4
239000003155 DNA primer Substances 0.000 description 4
TWRXJAOTZQYOKJ-UHFFFAOYSA-L Magnesium chloride Chemical compound [Mg+2].[Cl-].[Cl-] TWRXJAOTZQYOKJ-UHFFFAOYSA-L 0.000 description 4
229930006000 Sucrose Natural products 0.000 description 4
CZMRCDWAGMRECN-UGDNZRGBSA-N Sucrose Chemical compound O[C@H]1[C@H](O)[C@@H](CO)O[C@@]1(CO)O[C@@H]1[C@H](O)[C@@H](O)[C@H](O)[C@@H](CO)O1 CZMRCDWAGMRECN-UGDNZRGBSA-N 0.000 description 4
241000282898 Sus scrofa Species 0.000 description 4
230000009471 action Effects 0.000 description 4
230000002238 attenuated effect Effects 0.000 description 4
208000010717 cat disease Diseases 0.000 description 4
125000004122 cyclic group Chemical group 0.000 description 4
230000009089 cytolysis Effects 0.000 description 4
238000010790 dilution Methods 0.000 description 4
239000012895 dilution Substances 0.000 description 4
230000001939 inductive effect Effects 0.000 description 4
230000005764 inhibitory process Effects 0.000 description 4
238000007918 intramuscular administration Methods 0.000 description 4
210000003292 kidney cell Anatomy 0.000 description 4
210000004698 lymphocyte Anatomy 0.000 description 4
230000001404 mediated effect Effects 0.000 description 4
230000001681 protective effect Effects 0.000 description 4
210000004988 splenocyte Anatomy 0.000 description 4
229940031626 subunit vaccine Drugs 0.000 description 4
239000005720 sucrose Substances 0.000 description 4
210000002845 virion Anatomy 0.000 description 4
238000005406 washing Methods 0.000 description 4
102000002260 Alkaline Phosphatase Human genes 0.000 description 3
108020004774 Alkaline Phosphatase Proteins 0.000 description 3
108020005544 Antisense RNA Proteins 0.000 description 3
241000894006 Bacteria Species 0.000 description 3
108020004705 Codon Proteins 0.000 description 3
244000019459 Cynara cardunculus Species 0.000 description 3
235000019106 Cynara scolymus Nutrition 0.000 description 3
238000001712 DNA sequencing Methods 0.000 description 3
241000700662 Fowlpox virus Species 0.000 description 3
PEDCQBHIVMGVHV-UHFFFAOYSA-N Glycerine Chemical compound OCC(O)CO PEDCQBHIVMGVHV-UHFFFAOYSA-N 0.000 description 3
101001091385 Homo sapiens Kallikrein-6 Proteins 0.000 description 3
108090000144 Human Proteins Proteins 0.000 description 3
206010061598 Immunodeficiency Diseases 0.000 description 3
208000029462 Immunodeficiency disease Diseases 0.000 description 3
102000008070 Interferon-gamma Human genes 0.000 description 3
108010074328 Interferon-gamma Proteins 0.000 description 3
108090000143 Mouse Proteins Proteins 0.000 description 3
101100187130 Neurospora crassa (strain ATCC 24698 / 74-OR23-1A / CBS 708.71 / DSM 1257 / FGSC 987) nim-1 gene Proteins 0.000 description 3
MUBZPKHOEPUJKR-UHFFFAOYSA-N Oxalic acid Chemical compound OC(=O)C(O)=O MUBZPKHOEPUJKR-UHFFFAOYSA-N 0.000 description 3
238000012408 PCR amplification Methods 0.000 description 3
229930182555 Penicillin Natural products 0.000 description 3
JGSARLDLIJGVTE-MBNYWOFBSA-N Penicillin G Chemical compound N([C@H]1[C@H]2SC([C@@H](N2C1=O)C(O)=O)(C)C)C(=O)CC1=CC=CC=C1 JGSARLDLIJGVTE-MBNYWOFBSA-N 0.000 description 3
102000004160 Phosphoric Monoester Hydrolases Human genes 0.000 description 3
108090000608 Phosphoric Monoester Hydrolases Proteins 0.000 description 3
229920001213 Polysorbate 20 Polymers 0.000 description 3
108050008731 Poxvirus E2 Proteins 0.000 description 3
238000002123 RNA extraction Methods 0.000 description 3
HEMHJVSKTPXQMS-UHFFFAOYSA-M Sodium hydroxide Chemical compound [OH-].[Na+] HEMHJVSKTPXQMS-UHFFFAOYSA-M 0.000 description 3
HMNZFMSWFCAGGW-XPWSMXQVSA-N [3-[hydroxy(2-hydroxyethoxy)phosphoryl]oxy-2-[(e)-octadec-9-enoyl]oxypropyl] (e)-octadec-9-enoate Chemical compound CCCCCCCC\C=C\CCCCCCCC(=O)OCC(COP(O)(=O)OCCO)OC(=O)CCCCCCC\C=C\CCCCCCCC HMNZFMSWFCAGGW-XPWSMXQVSA-N 0.000 description 3
238000010521 absorption reaction Methods 0.000 description 3
-1 amino- Chemical class 0.000 description 3
235000016520 artichoke thistle Nutrition 0.000 description 3
239000012298 atmosphere Substances 0.000 description 3
230000001580 bacterial effect Effects 0.000 description 3
230000008901 benefit Effects 0.000 description 3
210000000170 cell membrane Anatomy 0.000 description 3
230000008859 change Effects 0.000 description 3
LOKCTEFSRHRXRJ-UHFFFAOYSA-I dipotassium trisodium dihydrogen phosphate hydrogen phosphate dichloride Chemical compound P(=O)(O)(O)[O-].[K+].P(=O)(O)([O-])[O-].[Na+].[Na+].[Cl-].[K+].[Cl-].[Na+] LOKCTEFSRHRXRJ-UHFFFAOYSA-I 0.000 description 3
238000002474 experimental method Methods 0.000 description 3
238000000605 extraction Methods 0.000 description 3
ZDXPYRJPNDTMRX-UHFFFAOYSA-N glutamine Natural products OC(=O)C(N)CCC(N)=O ZDXPYRJPNDTMRX-UHFFFAOYSA-N 0.000 description 3
230000002209 hydrophobic effect Effects 0.000 description 3
230000007813 immunodeficiency Effects 0.000 description 3
238000011534 incubation Methods 0.000 description 3
239000006166 lysate Substances 0.000 description 3
210000001161 mammalian embryo Anatomy 0.000 description 3
244000005700 microbiome Species 0.000 description 3
230000004048 modification Effects 0.000 description 3
238000012986 modification Methods 0.000 description 3
230000035772 mutation Effects 0.000 description 3
229940049954 penicillin Drugs 0.000 description 3
206010034674 peritonitis Diseases 0.000 description 3
239000002953 phosphate buffered saline Substances 0.000 description 3
239000000256 polyoxyethylene sorbitan monolaurate Substances 0.000 description 3
235000010486 polyoxyethylene sorbitan monolaurate Nutrition 0.000 description 3
239000000843 powder Substances 0.000 description 3
239000002244 precipitate Substances 0.000 description 3
238000004321 preservation Methods 0.000 description 3
230000003449 preventive effect Effects 0.000 description 3
230000001566 pro-viral effect Effects 0.000 description 3
230000035755 proliferation Effects 0.000 description 3
235000020183 skimmed milk Nutrition 0.000 description 3
229960005322 streptomycin Drugs 0.000 description 3
238000007920 subcutaneous administration Methods 0.000 description 3
239000000126 substance Substances 0.000 description 3
229910001868 water Inorganic materials 0.000 description 3
YBJHBAHKTGYVGT-ZKWXMUAHSA-N (+)-Biotin Chemical compound N1C(=O)N[C@@H]2[C@H](CCCCC(=O)O)SC[C@@H]21 YBJHBAHKTGYVGT-ZKWXMUAHSA-N 0.000 description 2
101150096316 5 gene Proteins 0.000 description 2
101150011812 AADAC gene Proteins 0.000 description 2
241001455214 Acinonyx jubatus Species 0.000 description 2
241000283690 Bos taurus Species 0.000 description 2
101710132601 Capsid protein Proteins 0.000 description 2
206010057248 Cell death Diseases 0.000 description 2
HEDRZPFGACZZDS-UHFFFAOYSA-N Chloroform Chemical compound ClC(Cl)Cl HEDRZPFGACZZDS-UHFFFAOYSA-N 0.000 description 2
101710094648 Coat protein Proteins 0.000 description 2
241000700626 Cowpox virus Species 0.000 description 2
102000053602 DNA Human genes 0.000 description 2
108010014303 DNA-directed DNA polymerase Proteins 0.000 description 2
102000016928 DNA-directed DNA polymerase Human genes 0.000 description 2
208000035240 Disease Resistance Diseases 0.000 description 2
238000002965 ELISA Methods 0.000 description 2
101150014767 EM gene Proteins 0.000 description 2
108010067770 Endopeptidase K Proteins 0.000 description 2
IAYPIBMASNFSPL-UHFFFAOYSA-N Ethylene oxide Chemical compound C1CO1 IAYPIBMASNFSPL-UHFFFAOYSA-N 0.000 description 2
241000701925 Feline parvovirus Species 0.000 description 2
ZHNUHDYFZUAESO-UHFFFAOYSA-N Formamide Chemical compound NC=O ZHNUHDYFZUAESO-UHFFFAOYSA-N 0.000 description 2
102000002464 Galactosidases Human genes 0.000 description 2
108010093031 Galactosidases Proteins 0.000 description 2
241000287828 Gallus gallus Species 0.000 description 2
DHMQDGOQFOQNFH-UHFFFAOYSA-N Glycine Chemical compound NCC(O)=O DHMQDGOQFOQNFH-UHFFFAOYSA-N 0.000 description 2
102100021181 Golgi phosphoprotein 3 Human genes 0.000 description 2
208000009329 Graft vs Host Disease Diseases 0.000 description 2
101710178376 Heat shock 70 kDa protein Proteins 0.000 description 2
108060003951 Immunoglobulin Proteins 0.000 description 2
206010062016 Immunosuppression Diseases 0.000 description 2
AGPKZVBTJJNPAG-WHFBIAKZSA-N L-isoleucine Chemical compound CC[C@H](C)[C@H](N)C(O)=O AGPKZVBTJJNPAG-WHFBIAKZSA-N 0.000 description 2
ROHFNLRQFUQHCH-YFKPBYRVSA-N L-leucine Chemical compound CC(C)C[C@H](N)C(O)=O ROHFNLRQFUQHCH-YFKPBYRVSA-N 0.000 description 2
ROHFNLRQFUQHCH-UHFFFAOYSA-N Leucine Natural products CC(C)CC(N)C(O)=O ROHFNLRQFUQHCH-UHFFFAOYSA-N 0.000 description 2
241000721701 Lynx Species 0.000 description 2
101710125418 Major capsid protein Proteins 0.000 description 2
101100233255 Mus musculus Ipp gene Proteins 0.000 description 2
101100513472 Mus musculus Minpp1 gene Proteins 0.000 description 2
101710141454 Nucleoprotein Proteins 0.000 description 2
241000282320 Panthera leo Species 0.000 description 2
ISWSIDIOOBJBQZ-UHFFFAOYSA-N Phenol Chemical compound OC1=CC=CC=C1 ISWSIDIOOBJBQZ-UHFFFAOYSA-N 0.000 description 2
208000007452 Plasmacytoma Diseases 0.000 description 2
101710083689 Probable capsid protein Proteins 0.000 description 2
241000125945 Protoparvovirus Species 0.000 description 2
108010008281 Recombinant Fusion Proteins Proteins 0.000 description 2
102000007056 Recombinant Fusion Proteins Human genes 0.000 description 2
206010051497 Rhinotracheitis Diseases 0.000 description 2
238000002105 Southern blotting Methods 0.000 description 2
230000006052 T cell proliferation Effects 0.000 description 2
108091008874 T cell receptors Proteins 0.000 description 2
230000005867 T cell response Effects 0.000 description 2
102000016266 T-Cell Antigen Receptors Human genes 0.000 description 2
IQFYYKKMVGJFEH-XLPZGREQSA-N Thymidine Chemical compound O=C1NC(=O)C(C)=CN1[C@@H]1O[C@H](CO)[C@@H](O)C1 IQFYYKKMVGJFEH-XLPZGREQSA-N 0.000 description 2
239000002671 adjuvant Substances 0.000 description 2
238000001042 affinity chromatography Methods 0.000 description 2
125000000539 amino acid group Chemical class 0.000 description 2
229960000723 ampicillin Drugs 0.000 description 2
AVKUERGKIZMTKX-NJBDSQKTSA-N ampicillin Chemical compound C1([C@@H](N)C(=O)N[C@H]2[C@H]3SC([C@@H](N3C2=O)C(O)=O)(C)C)=CC=CC=C1 AVKUERGKIZMTKX-NJBDSQKTSA-N 0.000 description 2
238000000137 annealing Methods 0.000 description 2
210000000612 antigen-presenting cell Anatomy 0.000 description 2
210000003719 b-lymphocyte Anatomy 0.000 description 2
102000005936 beta-Galactosidase Human genes 0.000 description 2
230000005540 biological transmission Effects 0.000 description 2
101150055766 cat gene Proteins 0.000 description 2
230000010261 cell growth Effects 0.000 description 2
230000001413 cellular effect Effects 0.000 description 2
239000003795 chemical substances by application Substances 0.000 description 2
239000013078 crystal Substances 0.000 description 2
230000034994 death Effects 0.000 description 2
238000004925 denaturation Methods 0.000 description 2
230000036425 denaturation Effects 0.000 description 2
238000001212 derivatisation Methods 0.000 description 2
238000013461 design Methods 0.000 description 2
239000012153 distilled water Substances 0.000 description 2
229940079593 drug Drugs 0.000 description 2
238000004520 electroporation Methods 0.000 description 2
239000003623 enhancer Substances 0.000 description 2
210000003527 eukaryotic cell Anatomy 0.000 description 2
238000011156 evaluation Methods 0.000 description 2
230000005713 exacerbation Effects 0.000 description 2
239000000945 filler Substances 0.000 description 2
239000000834 fixative Substances 0.000 description 2
239000007850 fluorescent dye Substances 0.000 description 2
238000001502 gel electrophoresis Methods 0.000 description 2
238000012224 gene deletion Methods 0.000 description 2
208000024908 graft versus host disease Diseases 0.000 description 2
230000036541 health Effects 0.000 description 2
125000000487 histidyl group Chemical group [H]N([H])C(C(=O)O*)C([H])([H])C1=C([H])N([H])C([H])=N1 0.000 description 2
230000007062 hydrolysis Effects 0.000 description 2
238000006460 hydrolysis reaction Methods 0.000 description 2
FDGQSTZJBFJUBT-UHFFFAOYSA-N hypoxanthine Chemical compound O=C1NC=NC2=C1NC=N2 FDGQSTZJBFJUBT-UHFFFAOYSA-N 0.000 description 2
230000001900 immune effect Effects 0.000 description 2
102000018358 immunoglobulin Human genes 0.000 description 2
230000001506 immunosuppresive effect Effects 0.000 description 2
230000006698 induction Effects 0.000 description 2
230000000977 initiatory effect Effects 0.000 description 2
238000011081 inoculation Methods 0.000 description 2
229960003130 interferon gamma Drugs 0.000 description 2
238000001990 intravenous administration Methods 0.000 description 2
229960000310 isoleucine Drugs 0.000 description 2
AGPKZVBTJJNPAG-UHFFFAOYSA-N isoleucine Natural products CCC(C)C(N)C(O)=O AGPKZVBTJJNPAG-UHFFFAOYSA-N 0.000 description 2
239000002502 liposome Substances 0.000 description 2
229910001629 magnesium chloride Inorganic materials 0.000 description 2
238000013507 mapping Methods 0.000 description 2
206010061289 metastatic neoplasm Diseases 0.000 description 2
238000000520 microinjection Methods 0.000 description 2
239000010413 mother solution Substances 0.000 description 2
FSVCQIDHPKZJSO-UHFFFAOYSA-L nitro blue tetrazolium dichloride Chemical compound [Cl-].[Cl-].COC1=CC(C=2C=C(OC)C(=CC=2)[N+]=2N(N=C(N=2)C=2C=CC=CC=2)C=2C=CC(=CC=2)[N+]([O-])=O)=CC=C1[N+]1=NC(C=2C=CC=CC=2)=NN1C1=CC=C([N+]([O-])=O)C=C1 FSVCQIDHPKZJSO-UHFFFAOYSA-L 0.000 description 2
238000011330 nucleic acid test Methods 0.000 description 2
235000015097 nutrients Nutrition 0.000 description 2
230000037361 pathway Effects 0.000 description 2
XOJVVFBFDXDTEG-UHFFFAOYSA-N pristane Chemical compound CC(C)CCCC(C)CCCC(C)CCCC(C)C XOJVVFBFDXDTEG-UHFFFAOYSA-N 0.000 description 2
210000001236 prokaryotic cell Anatomy 0.000 description 2
239000011535 reaction buffer Substances 0.000 description 2
230000009467 reduction Effects 0.000 description 2
230000019908 regulation of T cell activation Effects 0.000 description 2
230000003252 repetitive effect Effects 0.000 description 2
238000001228 spectrum Methods 0.000 description 2
238000010561 standard procedure Methods 0.000 description 2
230000004936 stimulating effect Effects 0.000 description 2
230000000638 stimulation Effects 0.000 description 2
238000007910 systemic administration Methods 0.000 description 2
238000010257 thawing Methods 0.000 description 2
NQSJDHNNJIQPNW-UHFFFAOYSA-K trisodium;trichloride Chemical compound [Na+].[Na+].[Na+].[Cl-].[Cl-].[Cl-] NQSJDHNNJIQPNW-UHFFFAOYSA-K 0.000 description 2
241000701447 unidentified baculovirus Species 0.000 description 2
PFFIDZXUXFLSSR-UHFFFAOYSA-N 1-methyl-N-[2-(4-methylpentan-2-yl)-3-thienyl]-3-(trifluoromethyl)pyrazole-4-carboxamide Chemical compound S1C=CC(NC(=O)C=2C(=NN(C)C=2)C(F)(F)F)=C1C(C)CC(C)C PFFIDZXUXFLSSR-UHFFFAOYSA-N 0.000 description 1
TVZGACDUOSZQKY-LBPRGKRZSA-N 4-aminofolic acid Chemical compound C1=NC2=NC(N)=NC(N)=C2N=C1CNC1=CC=C(C(=O)N[C@@H](CCC(O)=O)C(O)=O)C=C1 TVZGACDUOSZQKY-LBPRGKRZSA-N 0.000 description 1
101150039504 6 gene Proteins 0.000 description 1
RZVAJINKPMORJF-UHFFFAOYSA-N Acetaminophen Chemical compound CC(=O)NC1=CC=C(O)C=C1 RZVAJINKPMORJF-UHFFFAOYSA-N 0.000 description 1
241000360587 Agaue Species 0.000 description 1
241000772991 Aira Species 0.000 description 1
206010027654 Allergic conditions Diseases 0.000 description 1
241000710929 Alphavirus Species 0.000 description 1
239000004475 Arginine Substances 0.000 description 1
241000271566 Aves Species 0.000 description 1
208000035143 Bacterial infection Diseases 0.000 description 1
241000834597 Bagrus Species 0.000 description 1
DWRXFEITVBNRMK-UHFFFAOYSA-N Beta-D-1-Arabinofuranosylthymine Natural products O=C1NC(=O)C(C)=CN1C1C(O)C(O)C(CO)O1 DWRXFEITVBNRMK-UHFFFAOYSA-N 0.000 description 1
ZOXJGFHDIHLPTG-UHFFFAOYSA-N Boron Chemical compound [B] ZOXJGFHDIHLPTG-UHFFFAOYSA-N 0.000 description 1
240000002791 Brassica napus Species 0.000 description 1
235000011293 Brassica napus Nutrition 0.000 description 1
235000000540 Brassica rapa subsp rapa Nutrition 0.000 description 1
241000178270 Canarypox virus Species 0.000 description 1
241000680578 Canid alphaherpesvirus 1 Species 0.000 description 1
BVKZGUZCCUSVTD-UHFFFAOYSA-L Carbonate Chemical compound [O-]C([O-])=O BVKZGUZCCUSVTD-UHFFFAOYSA-L 0.000 description 1
102000000844 Cell Surface Receptors Human genes 0.000 description 1
108010001857 Cell Surface Receptors Proteins 0.000 description 1
241000498849 Chlamydiales Species 0.000 description 1
102000007644 Colony-Stimulating Factors Human genes 0.000 description 1
108010071942 Colony-Stimulating Factors Proteins 0.000 description 1
108020004635 Complementary DNA Proteins 0.000 description 1
108010062580 Concanavalin A Proteins 0.000 description 1
108091035707 Consensus sequence Proteins 0.000 description 1
102000012410 DNA Ligases Human genes 0.000 description 1
108010061982 DNA Ligases Proteins 0.000 description 1
108010041986 DNA Vaccines Proteins 0.000 description 1
108010008286 DNA nucleotidylexotransferase Proteins 0.000 description 1
230000006820 DNA synthesis Effects 0.000 description 1
229940021995 DNA vaccine Drugs 0.000 description 1
102100029764 DNA-directed DNA/RNA polymerase mu Human genes 0.000 description 1
102000016911 Deoxyribonucleases Human genes 0.000 description 1
108010053770 Deoxyribonucleases Proteins 0.000 description 1
241000702421 Dependoparvovirus Species 0.000 description 1
101100291267 Drosophila melanogaster Miga gene Proteins 0.000 description 1
239000006144 Dulbecco’s modiﬁed Eagle's medium Substances 0.000 description 1
101150013191 E gene Proteins 0.000 description 1
241000230501 Equine herpesvirus sp. Species 0.000 description 1
241000588724 Escherichia coli Species 0.000 description 1
102000020897 Formins Human genes 0.000 description 1
108091022623 Formins Proteins 0.000 description 1
206010017533 Fungal infection Diseases 0.000 description 1
101150079033 Gas7 gene Proteins 0.000 description 1
WQZGKKKJIJFFOK-GASJEMHNSA-N Glucose Natural products OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-GASJEMHNSA-N 0.000 description 1
239000004471 Glycine Substances 0.000 description 1
101800000342 Glycoprotein C Proteins 0.000 description 1
102000008949 Histocompatibility Antigens Class I Human genes 0.000 description 1
108010001336 Horseradish Peroxidase Proteins 0.000 description 1
241000701024 Human betaherpesvirus 5 Species 0.000 description 1
UGQMRVRMYYASKQ-UHFFFAOYSA-N Hypoxanthine nucleoside Natural products OC1C(O)C(CO)OC1N1C(NC=NC2=O)=C2N=C1 UGQMRVRMYYASKQ-UHFFFAOYSA-N 0.000 description 1
DGAQECJNVWCQMB-PUAWFVPOSA-M Ilexoside XXIX Chemical compound C[C@@H]1CC[C@@]2(CC[C@@]3(C(=CC[C@H]4[C@]3(CC[C@@H]5[C@@]4(CC[C@@H](C5(C)C)OS(=O)(=O)[O-])C)C)[C@@H]2[C@]1(C)O)C)C(=O)O[C@H]6[C@@H]([C@H]([C@@H]([C@H](O6)CO)O)O)O.[Na+] DGAQECJNVWCQMB-PUAWFVPOSA-M 0.000 description 1
102000014150 Interferons Human genes 0.000 description 1
108010050904 Interferons Proteins 0.000 description 1
102000015696 Interleukins Human genes 0.000 description 1
108010063738 Interleukins Proteins 0.000 description 1
108091092195 Intron Proteins 0.000 description 1
QNAYBMKLOCPYGJ-REOHCLBHSA-N L-alanine Chemical compound C[C@H](N)C(O)=O QNAYBMKLOCPYGJ-REOHCLBHSA-N 0.000 description 1
ODKSFYDXXFIFQN-BYPYZUCNSA-P L-argininium(2+) Chemical compound NC(=[NH2+])NCCC[C@H]([NH3+])C(O)=O ODKSFYDXXFIFQN-BYPYZUCNSA-P 0.000 description 1
CKLJMWTZIZZHCS-REOHCLBHSA-N L-aspartic acid Chemical compound OC(=O)[C@@H](N)CC(O)=O CKLJMWTZIZZHCS-REOHCLBHSA-N 0.000 description 1
WHUUTDBJXJRKMK-VKHMYHEASA-N L-glutamic acid Chemical compound OC(=O)[C@@H](N)CCC(O)=O WHUUTDBJXJRKMK-VKHMYHEASA-N 0.000 description 1
KDXKERNSBIXSRK-UHFFFAOYSA-N Lysine Natural products NCCCCC(N)C(O)=O KDXKERNSBIXSRK-UHFFFAOYSA-N 0.000 description 1
239000004472 Lysine Substances 0.000 description 1
108091054437 MHC class I family Proteins 0.000 description 1
241000124008 Mammalia Species 0.000 description 1
FQISKWAFAHGMGT-SGJOWKDISA-M Methylprednisolone sodium succinate Chemical compound [Na+].C([C@@]12C)=CC(=O)C=C1[C@@H](C)C[C@@H]1[C@@H]2[C@@H](O)C[C@]2(C)[C@@](O)(C(=O)COC(=O)CCC([O-])=O)CC[C@H]21 FQISKWAFAHGMGT-SGJOWKDISA-M 0.000 description 1
229910015667 MoO4 Inorganic materials 0.000 description 1
241000713869 Moloney murine leukemia virus Species 0.000 description 1
101100310622 Mus musculus Soga1 gene Proteins 0.000 description 1
208000031888 Mycoses Diseases 0.000 description 1
244000004005 Nypa fruticans Species 0.000 description 1
235000005305 Nypa fruticans Nutrition 0.000 description 1
108091034117 Oligonucleotide Proteins 0.000 description 1
108020002230 Pancreatic Ribonuclease Proteins 0.000 description 1
102000005891 Pancreatic ribonuclease Human genes 0.000 description 1
241000282376 Panthera tigris Species 0.000 description 1
108010010677 Phosphodiesterase I Proteins 0.000 description 1
108091000080 Phosphotransferase Proteins 0.000 description 1
241000709664 Picornaviridae Species 0.000 description 1
206010035226 Plasma cell myeloma Diseases 0.000 description 1
239000002202 Polyethylene glycol Substances 0.000 description 1
239000004793 Polystyrene Substances 0.000 description 1
108010076504 Protein Sorting Signals Proteins 0.000 description 1
201000004681 Psoriasis Diseases 0.000 description 1
241000282374 Puma concolor Species 0.000 description 1
229940022005 RNA vaccine Drugs 0.000 description 1
108091030071 RNAI Proteins 0.000 description 1
206010037742 Rabies Diseases 0.000 description 1
208000035415 Reinfection Diseases 0.000 description 1
241000702263 Reovirus sp. Species 0.000 description 1
108700008625 Reporter Genes Proteins 0.000 description 1
108091027981 Response element Proteins 0.000 description 1
101710135673 Retinal-specific phospholipid-transporting ATPase ABCA4 Proteins 0.000 description 1
102000006382 Ribonucleases Human genes 0.000 description 1
108010083644 Ribonucleases Proteins 0.000 description 1
240000004808 Saccharomyces cerevisiae Species 0.000 description 1
241000710960 Sindbis virus Species 0.000 description 1
FAPWRFPIFSIZLT-UHFFFAOYSA-M Sodium chloride Chemical compound [Na+].[Cl-] FAPWRFPIFSIZLT-UHFFFAOYSA-M 0.000 description 1
240000006394 Sorghum bicolor Species 0.000 description 1
235000011684 Sorghum saccharatum Nutrition 0.000 description 1
230000020385 T cell costimulation Effects 0.000 description 1
108010039203 Tripeptidyl-Peptidase 1 Proteins 0.000 description 1
102100034197 Tripeptidyl-peptidase 1 Human genes 0.000 description 1
241000700618 Vaccinia virus Species 0.000 description 1
241000700647 Variola virus Species 0.000 description 1
108010067390 Viral Proteins Proteins 0.000 description 1
101150095244 ac gene Proteins 0.000 description 1
230000002378 acidificating effect Effects 0.000 description 1
235000004279 alanine Nutrition 0.000 description 1
229960003896 aminopterin Drugs 0.000 description 1
239000003242 anti bacterial agent Substances 0.000 description 1
230000000844 anti-bacterial effect Effects 0.000 description 1
210000000628 antibody-producing cell Anatomy 0.000 description 1
239000008346 aqueous phase Substances 0.000 description 1
ODKSFYDXXFIFQN-UHFFFAOYSA-N arginine Natural products OC(=O)C(N)CCCNC(N)=N ODKSFYDXXFIFQN-UHFFFAOYSA-N 0.000 description 1
208000016063 arterial thoracic outlet syndrome Diseases 0.000 description 1
206010003246 arthritis Diseases 0.000 description 1
125000003118 aryl group Chemical group 0.000 description 1
210000003567 ascitic fluid Anatomy 0.000 description 1
229940009098 aspartate Drugs 0.000 description 1
230000001363 autoimmune Effects 0.000 description 1
230000010310 bacterial transformation Effects 0.000 description 1
239000003899 bactericide agent Substances 0.000 description 1
IQFYYKKMVGJFEH-UHFFFAOYSA-N beta-L-thymidine Natural products O=C1NC(=O)C(C)=CN1C1OC(CO)C(O)C1 IQFYYKKMVGJFEH-UHFFFAOYSA-N 0.000 description 1
230000003115 biocidal effect Effects 0.000 description 1
229960002685 biotin Drugs 0.000 description 1
235000020958 biotin Nutrition 0.000 description 1
239000011616 biotin Substances 0.000 description 1
230000037396 body weight Effects 0.000 description 1
238000010322 bone marrow transplantation Methods 0.000 description 1
229910052796 boron Inorganic materials 0.000 description 1
238000010804 cDNA synthesis Methods 0.000 description 1
239000001506 calcium phosphate Substances 0.000 description 1
229910000389 calcium phosphate Inorganic materials 0.000 description 1
235000011010 calcium phosphates Nutrition 0.000 description 1
230000006037 cell lysis Effects 0.000 description 1
238000012512 characterization method Methods 0.000 description 1
PZTQVMXMKVTIRC-UHFFFAOYSA-L chembl2028348 Chemical compound [Ca+2].[O-]S(=O)(=O)C1=CC(C)=CC=C1N=NC1=C(O)C(C([O-])=O)=CC2=CC=CC=C12 PZTQVMXMKVTIRC-UHFFFAOYSA-L 0.000 description 1
210000004978 chinese hamster ovary cell Anatomy 0.000 description 1
YTRQFSDWAXHJCC-UHFFFAOYSA-N chloroform;phenol Chemical compound ClC(Cl)Cl.OC1=CC=CC=C1 YTRQFSDWAXHJCC-UHFFFAOYSA-N 0.000 description 1
238000004587 chromatography analysis Methods 0.000 description 1
239000003593 chromogenic compound Substances 0.000 description 1
210000000349 chromosome Anatomy 0.000 description 1
239000003184 complementary RNA Substances 0.000 description 1
238000012790 confirmation Methods 0.000 description 1
238000001816 cooling Methods 0.000 description 1
230000000139 costimulatory effect Effects 0.000 description 1
238000012258 culturing Methods 0.000 description 1
PAFZNILMFXTMIY-UHFFFAOYSA-N cyclohexylamine Chemical class NC1CCCCC1 PAFZNILMFXTMIY-UHFFFAOYSA-N 0.000 description 1
108010057085 cytokine receptors Proteins 0.000 description 1
102000003675 cytokine receptors Human genes 0.000 description 1
210000001151 cytotoxic T lymphocyte Anatomy 0.000 description 1
230000006378 damage Effects 0.000 description 1
230000003412 degenerative effect Effects 0.000 description 1
239000008367 deionised water Substances 0.000 description 1
229910021641 deionized water Inorganic materials 0.000 description 1
239000007933 dermal patch Substances 0.000 description 1
239000008121 dextrose Substances 0.000 description 1
239000000539 dimer Substances 0.000 description 1
239000002552 dosage form Substances 0.000 description 1
230000008030 elimination Effects 0.000 description 1
238000003379 elimination reaction Methods 0.000 description 1
238000005516 engineering process Methods 0.000 description 1
239000000284 extract Substances 0.000 description 1
210000002950 fibroblast Anatomy 0.000 description 1
238000009472 formulation Methods 0.000 description 1
238000002825 functional assay Methods 0.000 description 1
229940044627 gamma-interferon Drugs 0.000 description 1
238000002523 gelfiltration Methods 0.000 description 1
108091008053 gene clusters Proteins 0.000 description 1
230000009368 gene silencing by RNA Effects 0.000 description 1
238000001415 gene therapy Methods 0.000 description 1
230000002068 genetic effect Effects 0.000 description 1
229940097043 glucuronic acid Drugs 0.000 description 1
229930195712 glutamate Natural products 0.000 description 1
101150021237 grim gene Proteins 0.000 description 1
238000010438 heat treatment Methods 0.000 description 1
210000003630 histaminocyte Anatomy 0.000 description 1
230000001744 histochemical effect Effects 0.000 description 1
238000007849 hot-start PCR Methods 0.000 description 1
230000032832 immune response to tumor cell Effects 0.000 description 1
238000002649 immunization Methods 0.000 description 1
238000003018 immunoassay Methods 0.000 description 1
230000001976 improved effect Effects 0.000 description 1
239000012535 impurity Substances 0.000 description 1
230000002779 inactivation Effects 0.000 description 1
238000010348 incorporation Methods 0.000 description 1
239000012678 infectious agent Substances 0.000 description 1
230000002401 inhibitory effect Effects 0.000 description 1
239000007924 injection Substances 0.000 description 1
238000002347 injection Methods 0.000 description 1
230000010354 integration Effects 0.000 description 1
229940079322 interferon Drugs 0.000 description 1
238000007912 intraperitoneal administration Methods 0.000 description 1
239000007928 intraperitoneal injection Substances 0.000 description 1
238000004255 ion exchange chromatography Methods 0.000 description 1
238000001155 isoelectric focusing Methods 0.000 description 1
229930027917 kanamycin Natural products 0.000 description 1
229960000318 kanamycin Drugs 0.000 description 1
SBUJHOSQTJFQJX-NOAMYHISSA-N kanamycin Chemical compound O[C@@H]1[C@@H](O)[C@H](O)[C@@H](CN)O[C@@H]1O[C@H]1[C@H](O)[C@@H](O[C@@H]2[C@@H]([C@@H](N)[C@H](O)[C@@H](CO)O2)O)[C@H](N)C[C@@H]1N SBUJHOSQTJFQJX-NOAMYHISSA-N 0.000 description 1
229930182823 kanamycin A Natural products 0.000 description 1
210000000265 leukocyte Anatomy 0.000 description 1
230000000670 limiting effect Effects 0.000 description 1
239000007788 liquid Substances 0.000 description 1
230000004807 localization Effects 0.000 description 1
239000000314 lubricant Substances 0.000 description 1
125000003588 lysine group Chemical group [H]N([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])(N([H])[H])C(*)=O 0.000 description 1
239000012139 lysis buffer Substances 0.000 description 1
108700021021 mRNA Vaccine Proteins 0.000 description 1
230000035800 maturation Effects 0.000 description 1
210000003574 melanophore Anatomy 0.000 description 1
238000002844 melting Methods 0.000 description 1
235000006109 methionine Nutrition 0.000 description 1
125000001360 methionine group Chemical class N[C@@H](CCSC)C(=O)* 0.000 description 1
229960004584 methylprednisolone Drugs 0.000 description 1
229960001293 methylprednisolone acetate Drugs 0.000 description 1
PLBHSZGDDKCEHR-LFYFAGGJSA-N methylprednisolone acetate Chemical compound C([C@@]12C)=CC(=O)C=C1[C@@H](C)C[C@@H]1[C@@H]2[C@@H](O)C[C@]2(C)[C@@](O)(C(=O)COC(C)=O)CC[C@H]21 PLBHSZGDDKCEHR-LFYFAGGJSA-N 0.000 description 1
239000011859 microparticle Substances 0.000 description 1
239000004005 microsphere Substances 0.000 description 1
238000012544 monitoring process Methods 0.000 description 1
201000000050 myeloid neoplasm Diseases 0.000 description 1
238000007857 nested PCR Methods 0.000 description 1
230000007935 neutral effect Effects 0.000 description 1
210000004940 nucleus Anatomy 0.000 description 1
230000003287 optical effect Effects 0.000 description 1
235000006408 oxalic acid Nutrition 0.000 description 1
230000003071 parasitic effect Effects 0.000 description 1
239000002245 particle Substances 0.000 description 1
230000001575 pathological effect Effects 0.000 description 1
230000007170 pathology Effects 0.000 description 1
210000005105 peripheral blood lymphocyte Anatomy 0.000 description 1
239000012071 phase Substances 0.000 description 1
150000002989 phenols Chemical class 0.000 description 1
230000026731 phosphorylation Effects 0.000 description 1
238000006366 phosphorylation reaction Methods 0.000 description 1
102000020233 phosphotransferase Human genes 0.000 description 1
239000004014 plasticizer Substances 0.000 description 1
238000007747 plating Methods 0.000 description 1
238000002264 polyacrylamide gel electrophoresis Methods 0.000 description 1
230000008488 polyadenylation Effects 0.000 description 1
229920001223 polyethylene glycol Polymers 0.000 description 1
229920000642 polymer Polymers 0.000 description 1
229920002223 polystyrene Polymers 0.000 description 1
230000004815 positive regulation of T cell activation Effects 0.000 description 1
230000004492 positive regulation of T cell proliferation Effects 0.000 description 1
230000002028 premature Effects 0.000 description 1
230000008569 process Effects 0.000 description 1
238000011002 quantification Methods 0.000 description 1
230000009257 reactivity Effects 0.000 description 1
238000010188 recombinant method Methods 0.000 description 1
230000006798 recombination Effects 0.000 description 1
238000005215 recombination Methods 0.000 description 1
230000026267 regulation of growth Effects 0.000 description 1
230000010076 replication Effects 0.000 description 1
238000011160 research Methods 0.000 description 1
230000017702 response to host Effects 0.000 description 1
230000001177 retroviral effect Effects 0.000 description 1
238000007790 scraping Methods 0.000 description 1
238000007789 sealing Methods 0.000 description 1
230000028327 secretion Effects 0.000 description 1
239000013049 sediment Substances 0.000 description 1
238000000926 separation method Methods 0.000 description 1
101150083186 siaA gene Proteins 0.000 description 1
229910052709 silver Inorganic materials 0.000 description 1
239000004332 silver Substances 0.000 description 1
239000011734 sodium Substances 0.000 description 1
229910052708 sodium Inorganic materials 0.000 description 1
239000007790 solid phase Substances 0.000 description 1
241000894007 species Species 0.000 description 1
238000003756 stirring Methods 0.000 description 1
238000013268 sustained release Methods 0.000 description 1
239000012730 sustained-release form Substances 0.000 description 1
206010048627 thoracic outlet syndrome Diseases 0.000 description 1
229940104230 thymidine Drugs 0.000 description 1
230000000699 topical effect Effects 0.000 description 1
238000004481 total suppression of sideband Methods 0.000 description 1
230000005030 transcription termination Effects 0.000 description 1
238000012546 transfer Methods 0.000 description 1
QORWJWZARLRLPR-UHFFFAOYSA-H tricalcium bis(phosphate) Chemical compound [Ca+2].[Ca+2].[Ca+2].[O-]P([O-])([O-])=O.[O-]P([O-])([O-])=O QORWJWZARLRLPR-UHFFFAOYSA-H 0.000 description 1
230000005740 tumor formation Effects 0.000 description 1
230000004614 tumor growth Effects 0.000 description 1
241000701161 unidentified adenovirus Species 0.000 description 1
241001430294 unidentified retrovirus Species 0.000 description 1
229940125575 vaccine candidate Drugs 0.000 description 1
229960004854 viral vaccine Drugs 0.000 description 1
238000012800 visualization Methods 0.000 description 1
230000003442 weekly effect Effects 0.000 description 1
239000008760 zaizhang I Substances 0.000 description 1
DGVVWUTYPXICAM-UHFFFAOYSA-N β‐Mercaptoethanol Chemical compound OCCS DGVVWUTYPXICAM-UHFFFAOYSA-N 0.000 description 1

Classifications

- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
- C12N15/09—Recombinant DNA-technology
- C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
- C12N15/79—Vectors or expression systems specially adapted for eukaryotic hosts
- C12N15/85—Vectors or expression systems specially adapted for eukaryotic hosts for animal cells
- C12N15/86—Viral vectors
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A61P31/14—Antivirals for RNA viruses
- A61P31/18—Antivirals for RNA viruses for HIV
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
- A61P35/02—Antineoplastic agents specific for leukemia
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
- A61P37/04—Immunostimulants
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
- A61P37/06—Immunosuppressants, e.g. drugs for graft rejection
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P39/00—General protective or antinoxious agents
- A61P39/02—Antidotes
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/705—Receptors; Cell surface antigens; Cell surface determinants
- C07K14/70503—Immunoglobulin superfamily
- C07K14/70532—B7 molecules, e.g. CD80, CD86
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K48/00—Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases; Gene therapy
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2710/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA dsDNA viruses
- C12N2710/00011—Details
- C12N2710/16011—Herpesviridae
- C12N2710/16041—Use of virus, viral particle or viral elements as a vector
- C12N2710/16043—Use of virus, viral particle or viral elements as a vector viral genome or elements thereof as genetic vector
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2710/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA dsDNA viruses
- C12N2710/00011—Details
- C12N2710/24011—Poxviridae
- C12N2710/24041—Use of virus, viral particle or viral elements as a vector
- C12N2710/24043—Use of virus, viral particle or viral elements as a vector viral genome or elements thereof as genetic vector
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2830/00—Vector systems having a special element relevant for transcription
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2830/00—Vector systems having a special element relevant for transcription
- C12N2830/60—Vector systems having a special element relevant for transcription from viruses
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2840/00—Vectors comprising a special translation-regulating system
- C12N2840/20—Vectors comprising a special translation-regulating system translation of more than one cistron
- C12N2840/203—Vectors comprising a special translation-regulating system translation of more than one cistron having an IRES

Landscapes

Health & Medical Sciences (AREA)
Life Sciences & Earth Sciences (AREA)
Chemical & Material Sciences (AREA)
Organic Chemistry (AREA)
General Health & Medical Sciences (AREA)
Immunology (AREA)
Engineering & Computer Science (AREA)
Medicinal Chemistry (AREA)
Bioinformatics & Cheminformatics (AREA)
Chemical Kinetics & Catalysis (AREA)
Animal Behavior & Ethology (AREA)
Pharmacology & Pharmacy (AREA)
Public Health (AREA)
Veterinary Medicine (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
General Chemical & Material Sciences (AREA)
Genetics & Genomics (AREA)
Zoology (AREA)
Virology (AREA)
Biomedical Technology (AREA)
General Engineering & Computer Science (AREA)
Wood Science & Technology (AREA)
Biotechnology (AREA)
Molecular Biology (AREA)
Biochemistry (AREA)
Oncology (AREA)
Biophysics (AREA)
Plant Pathology (AREA)
Communicable Diseases (AREA)
Microbiology (AREA)
Physics & Mathematics (AREA)
Toxicology (AREA)
Cell Biology (AREA)
Transplantation (AREA)
AIDS & HIV (AREA)
Tropical Medicine & Parasitology (AREA)
Hematology (AREA)
Gastroenterology & Hepatology (AREA)
Proteomics, Peptides & Aminoacids (AREA)
Micro-Organisms Or Cultivation Processes Thereof (AREA)

UA2000116863A 1998-05-01 1999-04-30 Therapeutic vector expressing foreign dna, coding cat's cd80, cat's cd86, cat's cd28 or cat's ctla-4 and use thereof UA73718C2 (en)

Applications Claiming Priority (2)

Application Number	Priority Date	Filing Date	Title
US7171198A	1998-05-01	1998-05-01
PCT/US1999/009504 WO1999057295A1 (en)	1998-05-01	1999-04-30	Recombinant virus expressing foreign dna encoding feline cd80, feline ctla-4 or feline cd86 and uses thereof

Publications (1)

Publication Number	Publication Date
UA73718C2 true UA73718C2 (en)	2005-09-15

Family

ID=22103082

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
UA2000116863A UA73718C2 (en)	1998-05-01	1999-04-30	Therapeutic vector expressing foreign dna, coding cat's cd80, cat's cd86, cat's cd28 or cat's ctla-4 and use thereof

Country Status (19)

Country	Link
EP (1)	EP1073759B1 (cs)
JP (2)	JP2002513581A (cs)
KR (1)	KR100796799B1 (cs)
AT (1)	ATE511545T1 (cs)
AU (1)	AU761755B2 (cs)
BR (1)	BR9915970A (cs)
CA (1)	CA2327528C (cs)
CZ (1)	CZ20003934A3 (cs)
ES (1)	ES2367245T3 (cs)
HU (1)	HUP0200320A3 (cs)
IL (2)	IL139372A0 (cs)
NO (1)	NO20005482L (cs)
NZ (1)	NZ507793A (cs)
PL (1)	PL199359B1 (cs)
RU (1)	RU2244006C2 (cs)
SK (1)	SK16162000A3 (cs)
UA (1)	UA73718C2 (cs)
WO (1)	WO1999057295A1 (cs)
ZA (1)	ZA200006124B (cs)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US7078512B2 (en)	1998-05-01	2006-07-18	Schering-Plough Animal Health Corporation	Nucleic acid encoding feline CD86
AU784551B2 (en) *	1999-10-06	2006-05-04	Trustees Of The University Of Pennsylvania, The	Cell targeting compositions and methods of using the same
RU2250260C1 (ru) *	2003-09-26	2005-04-20	Федеральное государственное учреждение "Всероссийский государственный центр качества и стандартизации лекарственных средств для животных и кормов" (ФГУ ВГНКИ )	ШТАММ Feline coronavirus, ИСПОЛЬЗУЕМЫЙ ДЛЯ КОНТРОЛЯ ИММУНОГЕННОЙ АКТИВНОСТИ ВАКЦИН И ИЗГОТОВЛЕНИЯ БИОПРЕПАРАТОВ ДЛЯ ДИАГНОСТИКИ ИНФЕКЦИОННОГО ПЕРИТОНИТА КОШЕК
MX2007009524A (es)	2005-03-08	2008-03-04	Kenton S R L	Antigenos recombinantes quimericos de toxoplasma gondii.
GB201601498D0 (en)	2016-01-27	2016-03-09	Pirbright Inst The	Coronavirus
US11013798B2 (en)	2016-03-21	2021-05-25	South Dakota Board Of Regents	Orf virus-based platform for vaccine delivery

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
AU648261B2 (en) *	1989-08-18	1994-04-21	Novartis Vaccines And Diagnostics, Inc.	Recombinant retroviruses delivering vector constructs to target cells
EP0576092B1 (en) *	1992-06-26	2002-10-16	Akzo Nobel N.V.	Recombinant Feline herpesvirus vaccine
JP3529134B2 (ja) *	1992-07-30	2004-05-24	アクゾ・ノベル・エヌ・ベー	組換えネコヘルペスウイルスのベクターワクチン
US6084067A (en) *	1993-07-26	2000-07-04	Dana-Farber Cancer Institute	CTLA4/CD28 ligands and uses therefor
TW377373B (en) *	1993-09-22	1999-12-21	Wyeth Corp	Recombinant raccoon pox viruses and their use as an effective vaccine against feline infectious peritonitis virus disease
DE69519521T2 (de) *	1994-10-03	2001-06-28	The Government Of The United States Of America, As Represented By The Secretary National Institute Of Health	Zusammensetzung enthaltend ein antigen exprimierendes rekombinantes virus und ein immunstimulierendes molekül exprimierendes rekombinantes virus
US6221361B1 (en) *	1995-01-19	2001-04-24	Syntro Corporation	Recombinant swinepox virus
US5820869A (en) *	1995-06-07	1998-10-13	American Home Products Corporation	Recombinant raccoon pox viruses and their use as an effective vaccine against feline immunodeficiency virus infection

1999
- 1999-04-30 CA CA2327528A patent/CA2327528C/en not_active Expired - Fee Related
- 1999-04-30 HU HU0200320A patent/HUP0200320A3/hu unknown
- 1999-04-30 EP EP99922763A patent/EP1073759B1/en not_active Expired - Lifetime
- 1999-04-30 ES ES99922763T patent/ES2367245T3/es not_active Expired - Lifetime
- 1999-04-30 UA UA2000116863A patent/UA73718C2/uk unknown
- 1999-04-30 PL PL346012A patent/PL199359B1/pl not_active IP Right Cessation
- 1999-04-30 BR BR9915970-8A patent/BR9915970A/pt not_active Application Discontinuation
- 1999-04-30 IL IL13937299A patent/IL139372A0/xx unknown
- 1999-04-30 WO PCT/US1999/009504 patent/WO1999057295A1/en not_active Ceased
- 1999-04-30 CZ CZ20003934A patent/CZ20003934A3/cs unknown
- 1999-04-30 AT AT99922763T patent/ATE511545T1/de not_active IP Right Cessation
- 1999-04-30 NZ NZ507793A patent/NZ507793A/en unknown
- 1999-04-30 AU AU39688/99A patent/AU761755B2/en not_active Ceased
- 1999-04-30 JP JP2000547248A patent/JP2002513581A/ja not_active Withdrawn
- 1999-04-30 KR KR1020007012144A patent/KR100796799B1/ko not_active Expired - Fee Related
- 1999-04-30 SK SK1616-2000A patent/SK16162000A3/sk unknown
- 1999-04-30 RU RU2000130223/13A patent/RU2244006C2/ru not_active IP Right Cessation
2000
- 2000-10-30 IL IL139372A patent/IL139372A/en not_active IP Right Cessation
- 2000-10-30 ZA ZA200006124A patent/ZA200006124B/en unknown
- 2000-10-31 NO NO20005482A patent/NO20005482L/no not_active Application Discontinuation
2009
- 2009-04-06 JP JP2009091649A patent/JP2009178163A/ja active Pending

Also Published As

Publication number	Publication date
HUP0200320A3 (en)	2006-03-28
IL139372A (en)	2010-11-30
ES2367245T8 (es)	2011-12-09
PL199359B1 (pl)	2008-09-30
AU761755B2 (en)	2003-06-12
ATE511545T1 (de)	2011-06-15
HK1032606A1 (en)	2001-07-27
EP1073759A1 (en)	2001-02-07
EP1073759B1 (en)	2011-06-01
CZ20003934A3 (cs)	2001-09-12
CA2327528C (en)	2010-10-12
KR100796799B1 (ko)	2008-01-22
SK16162000A3 (sk)	2001-12-03
JP2009178163A (ja)	2009-08-13
AU3968899A (en)	1999-11-23
HUP0200320A2 (hu)	2002-05-29
BR9915970A (pt)	2001-12-04
KR20010085242A (ko)	2001-09-07
RU2244006C2 (ru)	2005-01-10
WO1999057295A1 (en)	1999-11-11
JP2002513581A (ja)	2002-05-14
NO20005482L (no)	2000-12-27
ZA200006124B (en)	2002-04-02
ES2367245T3 (es)	2011-10-31
IL139372A0 (en)	2001-11-25
CA2327528A1 (en)	1999-11-11
NZ507793A (en)	2003-05-30
NO20005482D0 (no)	2000-10-31
PL346012A1 (en)	2002-01-14

Publication	Publication Date	Title
US6537594B1 (en)	2003-03-25	Vaccina virus comprising cytokine and/or tumor associated antigen genes
US6780407B1 (en)	2004-08-24	Pox virus comprising DNA sequences encoding CEA and B7 antigen
US20040228842A1 (en)	2004-11-18	Compositions and methods for cytomegalovirus treatment
JP2001520507A (ja)	2001-10-30	組換えポックスウイルス−サイトメガロウイルス組成物および使用
TWI295322B (en)	2008-04-01	Capsid protein of feline calicivirus strain 431 and g1, dna fragments encoding them and immunogenic preparation comprising the same
Franceschi et al.	2011	Immunization of knock-out α/β interferon receptor mice against lethal bluetongue infection with a BoHV-4-based vector expressing BTV-8 VP2 antigen
HUT62325A (en)	1993-04-28	Chicken anaemia virus vaccine and diagnostic
US5661006A (en)	1997-08-26	DNA encoding the Canine coronavirus spike protein
UA73718C2 (en)	2005-09-15	Therapeutic vector expressing foreign dna, coding cat's cd80, cat's cd86, cat's cd28 or cat's ctla-4 and use thereof
JPH11511961A (ja)	1999-10-19	組換えポックスウイルス−カリシウイルス［ウサギ出血疾患ウイルス（ｒｈｄｖ）］組成物および使用
CA2127700C (en)	2006-06-20	Marek's disease virus recombinant poxvirus vaccine
US20130295133A1 (en)	2013-11-07	Recombinant virus expressing foreign dna encoding feline cd80, feline cd86, feline cd28, or feline ctla-4 and uses thereof
RU2263145C2 (ru)	2005-10-27	Выделенная нуклеиновая кислота, кодирующая лиганд cd86 кошки, диагностический олигонуклеотид, клонирующий вектор, вакцина, способы индукции или подавления иммунитета у кошки
Redwood et al.	2007	Viral vectored immunocontraception: screening of multiple fertility antigens using murine cytomegalovirus as a vaccine vector
EP0830452A1 (en)	1998-03-25	Immune-evading proteins
KR20240019135A (ko)	2024-02-14	작제물과 면역자극 화합물의 공동발현
Munro et al.	1999	Characteristics of glycoprotein B of equine herpesvirus 1 expressed by a recombinant baculovirus
ITMI950676A1 (it)	1996-10-04	Vaccini polinucleotidici
EP4585220A1 (en)	2025-07-16	Novel use of oncolytic virus
WO2019145739A1 (en)	2019-08-01	Lassa virus antigenic composition
CA3186250A1 (en)	2022-01-20	Vaccine composition for preventing severe acute respiratory syndrome coronavirus 2 infection
CN117467620A (zh)	2024-01-30	一种抗鸡ctla-4单克隆抗体及其应用
HK1032606B (en)	2011-10-07	Recombinant virus expressing foreign dna encoding feline cd80, feline cd28, feline ctla-4 or feline cd86 and uses thereof